Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Breast 8 Lymphoid 4 Thoracic 2 Other 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Melanoma 1 Cardiotoxicity 1

Interventions

Blood Specimen Collection 22 Surveys and Questionnaires 19 Nivolumab 14 Ipilimumab 12 pembrolizumab 11 Gene Expression Profiling 11 Biopsy 10 trametinib 9 dabrafenib 8 Flow Cytometry 8 Specimen Handling 7 Polymerase Chain Reaction 7 Tomography, Optical Coherence 6 Therapeutics 6 Immunohistochemistry 6 Imiquimod 6 Amplified Fragment Length Polymorphism Analysis 6 Watchful Waiting 5 Psychiatric Rehabilitation 5 Immunotherapy 5 Data Collection 5 3-ingenyl angelate 5 Mohs Surgery 4 Microarray Analysis 4 Interviews as Topic 4 Immunoenzyme Techniques 4 Drug Therapy 4 Dermoscopy 4 sonidegib 3 encorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Echocardiography × Dermatologic × Clear all

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡